| Jill S Conner, SLP | |
|
402 15th Ave Se, #100, Puyallup, WA 98372-3709 | |
| (253) 697-5200 | |
| (253) 697-5145 |
| Full Name | Jill S Conner |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 402 15th Ave Se, Puyallup, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386782589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00003004 (Washington) | Primary |
| Provider Name | Multicare Health System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons.
On February 11, 2011, the Appropriations Committee of the U.S. House of Representatives released details of the proposed Continuing Resolution (CR) for fiscal year 2011. The CR would fund the government through the end of September of this year.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
SMALL and with a life cycle of just two weeks, fruit flies are seen by many as pests and a problem all year round. However, for nearly a century, the humble insect, officially known as Drosophila melanogaster, which measures no more than 3mm, has performed a vital role in genetics and developmental biology.Fruit flies are genetically diverse and easy to use in research, helping scientists in a variety of studies, from how the brain functions to how cancer develops.
When getting vaccinated against covid-19, there's no sense being picky. You should take the first authorized vaccine that's offered, experts say.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill S Conner, SLP 402 15th Ave Se, #100, Puyallup, WA 98372-3709 Ph: (253) 697-5200 | Jill S Conner, SLP 402 15th Ave Se, #100, Puyallup, WA 98372-3709 Ph: (253) 697-5200 |
News Archive
A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons.
On February 11, 2011, the Appropriations Committee of the U.S. House of Representatives released details of the proposed Continuing Resolution (CR) for fiscal year 2011. The CR would fund the government through the end of September of this year.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
SMALL and with a life cycle of just two weeks, fruit flies are seen by many as pests and a problem all year round. However, for nearly a century, the humble insect, officially known as Drosophila melanogaster, which measures no more than 3mm, has performed a vital role in genetics and developmental biology.Fruit flies are genetically diverse and easy to use in research, helping scientists in a variety of studies, from how the brain functions to how cancer develops.
When getting vaccinated against covid-19, there's no sense being picky. You should take the first authorized vaccine that's offered, experts say.
› Verified 5 days ago
Ms. Angela Farnsworth, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 214 W Main, Puyallup, WA 98371 Phone: 253-841-8700 | |
Mrs. Amrita Nambiar, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 12th Ave Se, Puyallup, WA 98372 Phone: 253-841-3422 | |
Kaara Fairbanks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2929 5th Ave Ne Ste A, Puyallup, WA 98372 Phone: 253-447-8216 | |
Mrs. Nicole Malene Bosch, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 214 W Main, Puyallup, WA 98371 Phone: 253-841-8700 | |
Teletalk Speech Therapy Services Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17442 129th Ave E, Puyallup, WA 98374 Phone: 516-510-5963 | |
Robert Michael Shields, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 402 15th Ave Se Ste 100, Puyallup, WA 98372 Phone: 253-697-5200 Fax: 253-697-5248 | |
Dana Welter, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10324 Canyon Rd E, Puyallup, WA 98373 Phone: 360-584-6918 |